New Treatment Approved for Duchenne muscular dystrophy (DMD)

February 13, 2017

The FDA has just granted approval of deflazacort (brand name Emflaza) for the treatment of Duchenne muscular dystrophy (DMD). This is the third drug approved by the FDA in six months for our families! Thank you all for the countless hours you invest into MDA’s mission and the golf tournament that make these milestones possible!

You can read more about this news here.

About Mansfield Energy Corp:

For 60 years, Mansfield has been creatively solving commercial, industrial, and municipal customers’ most demanding energy procurement, supply, and logistics challenges. Today, the company provides energy commodities and related services to 6,000 customers in 18,000 locations across the U.S. and Canada. The company’s expertise covers a broad range of transportation and facilities energy from traditional petroleum products, CNG, renewable fuels, and specialty chemicals to power and natural gas. Mansfield employees are committed to their customers’ success, abiding by five core principles - Integrity, Excellence, Conscientiousness, Innovation, and Personal Service. The company is headquartered in Gainesville, GA (just north of Atlanta) with regional operations centers located in Chicago, Dallas, Denver, Houston, Los Angeles, Minneapolis, Bloomington, MN, and Calgary, Alberta Canada.

For more information about Mansfield, call 800-695-6626, or visit our website at